This inventor holds 4 USPTO granted patents and 4 published patent applications and 1 EPO patent. Top assignees: Indevus Pharmaceuticals, Inc., University of Massachusetts. Active years: 2002-2009.
Company Filing History:
Years Active: 2002-2009
Title: The Innovations of Robert B. Zurier
Introduction
Robert B. Zurier is a notable inventor based in Princeton, MA (US). He has made significant contributions to the field of lipid metabolism and cannabinoid research. With a total of four patents to his name, Zurier's work has implications for treating various health conditions.
Latest Patents
Zurier's latest patents include innovative lipid-amino acid conjugates and methods of use. These conjugates, specifically N-fatty acid-amino acid conjugates and J-prostanoid-amino acid conjugates, are designed for treating conditions related to dysfunctional lipid metabolism, insulin sensitivity, glucose homeostasis, and inflammation. Additionally, he has developed methods for decreasing cell proliferation using (3R,4R)-Δ8-tetrahydrocannabinol-11-oic acids. This invention focuses on the application of cannabinoid compounds, which are derivatives of tetrahydrocannabinol, to reduce cell proliferation in mammals.
Career Highlights
Throughout his career, Robert B. Zurier has worked with prominent organizations such as Indevus Pharmaceuticals, Inc. and the University of Massachusetts. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.
Collaborations
Zurier has collaborated with esteemed colleagues, including Lawrence Recht and Sumner Burstein. These partnerships have further enriched his research endeavors and innovations.
Conclusion
Robert B. Zurier's contributions to the fields of lipid metabolism and cannabinoid research highlight his role as an influential inventor. His patents and collaborations reflect a commitment to advancing medical science and improving health outcomes.